Allogene Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Allogene Therapeutics, Inc. (ALLO) reported Increase (Decrease) in Other Noncurrent Liabilities of $672.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-12
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was $356.00K, a 25.80% increase year-over-year.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was $316.00K, a 92.68% increase year-over-year.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was $329.00K, a 246.32% increase year-over-year.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $359.00K, a 212.17% increase year-over-year.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $1.14M, a 338.22% increase from fiscal 2024.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2024 was $259.00K.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was -$611.00K.
- Allogene Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$1.88M, a 306.81% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 1 month | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 3 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 12 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $672.00K 10-Q · filed 2026-08-12 | $1.00M derived: sum of 3 quarters · filed 2026-08-12 | $1.36M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2026-03-31 | $316.00K 10-Q · filed 2026-05-13 | $645.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.00M derived: sum of 3 quarters · filed 2026-05-13 | $1.29M derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2025-12-31 | $329.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $688.00K derived: sum of 2 quarters · filed 2026-03-12 | $971.00K derived: sum of 3 quarters · filed 2026-08-12 | $1.14M 10-K · filed 2026-03-12 | |||||
| 2025-09-30 | $359.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $642.00K derived: sum of 2 quarters · filed 2026-08-12 | $806.00K 10-Q · filed 2025-11-06 | $901.00K derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2025-06-30 | $283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $447.00K 10-Q · filed 2026-08-12 | $542.00K derived: sum of 3 quarters · filed 2026-08-12 | $657.00K derived: sum of 4 quarters · filed 2026-08-12 | |||||
| 2025-03-31 | $164.00K 10-Q · filed 2026-05-13 | $259.00K derived: sum of 2 quarters · filed 2026-05-13 | $374.00K derived: sum of 3 quarters · filed 2026-05-13 | $415.00K derived: sum of 4 quarters · filed 2026-05-13 | |||||
| 2024-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $210.00K derived: sum of 2 quarters · filed 2026-03-12 | $251.00K derived: sum of 3 quarters · filed 2026-03-12 | $259.00K 10-K · filed 2026-03-12 | |||||
| 2024-09-30 | $115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $156.00K derived: sum of 2 quarters · filed 2025-11-06 | $164.00K 10-Q · filed 2025-11-06 | $168.00K derived: sum of 4 quarters · filed 2025-11-06 | |||||
| 2024-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $49.00K 10-Q · filed 2025-08-13 | $53.00K derived: sum of 3 quarters · filed 2025-08-13 | $59.00K derived: sum of 4 quarters · filed 2025-08-13 | |||||
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-13 | $12.00K derived: sum of 2 quarters · filed 2025-05-13 | $18.00K derived: sum of 3 quarters · filed 2025-05-13 | $23.00K derived: sum of 4 quarters · filed 2025-05-13 | |||||
| 2023-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $10.00K derived: sum of 2 quarters · filed 2025-03-13 | $15.00K derived: sum of 3 quarters · filed 2025-03-13 | -$611.00K 10-K · filed 2025-03-13 | |||||
| 2023-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $11.00K derived: sum of 2 quarters · filed 2024-11-07 | -$615.00K 10-Q · filed 2024-11-07 | -$83.00K 10-Q · filed 2023-11-02 | -$1.04M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$621.00K 10-Q · filed 2024-08-07 | -$46.00K 10-Q · filed 2023-08-02 | -$1.05M derived: sum of 3 quarters · filed 2024-08-07 | -$1.48M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | -$626.00K 10-Q · filed 2024-05-13 | -$59.00K 10-Q · filed 2023-05-03 | -$1.05M derived: sum of 2 quarters · filed 2024-05-13 | -$1.48M derived: sum of 3 quarters · filed 2024-05-13 | -$1.91M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | -$428.00K derived: 10-K/A 12 month − 10-K 9 month · filed 2024-03-14 | -$854.00K derived: sum of 2 quarters · filed 2024-03-14 | -$1.28M derived: sum of 3 quarters · filed 2024-03-14 | -$1.88M 10-K/A · filed 2024-03-14 | -$2.56M 10-K · filed 2023-02-28 | ||||
| 2022-09-30 | -$426.00K derived: 10-K 9 month − 10-K 6 month · filed 2024-03-14 | -$853.00K derived: sum of 2 quarters · filed 2024-03-14 | -$1.45M 10-K · filed 2024-03-14 | -$2.09M 10-Q · filed 2022-11-02 | -$2.64M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-06-30 | -$427.00K derived: 10-K 6 month − 10-K 3 month · filed 2024-03-14 | -$1.03M 10-K · filed 2024-03-14 | -$1.57M 10-Q · filed 2022-08-09 | -$2.21M derived: sum of 3 quarters · filed 2024-03-14 | -$2.74M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-03-31 | -$601.00K 10-K · filed 2024-03-14 | -$635.00K 10-Q · filed 2022-05-04 | -$1.78M derived: sum of 2 quarters · filed 2024-03-14 | -$2.31M derived: sum of 3 quarters · filed 2024-03-14 | $601.00K derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2021-12-31 | -$1.18M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-14 | -$1.71M derived: sum of 2 quarters · filed 2024-03-14 | $1.20M derived: sum of 3 quarters · filed 2024-03-14 | $910.00K 10-K/A · filed 2024-03-14 | $1.04M 10-K · filed 2022-02-23 | ||||
| 2021-09-30 | -$530.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $2.38M derived: sum of 2 quarters · filed 2022-11-02 | $2.09M 10-Q · filed 2022-11-02 | $3.02M derived: sum of 4 quarters · filed 2024-03-14 | |||||
| 2021-06-30 | $2.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.62M 10-Q · filed 2022-08-09 | $3.56M derived: sum of 3 quarters · filed 2024-03-14 | $3.19M derived: sum of 4 quarters · filed 2024-03-14 | |||||
| 2021-03-31 | -$292.00K 10-Q · filed 2022-05-04 | $641.00K derived: sum of 2 quarters · filed 2024-03-14 | $271.00K derived: sum of 3 quarters · filed 2024-03-14 | -$216.00K derived: sum of 4 quarters · filed 2024-03-14 | |||||
| 2020-12-31 | $933.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-14 | $563.00K derived: sum of 2 quarters · filed 2024-03-14 | $76.00K derived: sum of 3 quarters · filed 2024-03-14 | -$625.00K 10-K/A · filed 2024-03-14 | -$1.27M 10-K · filed 2021-02-25 | ||||
| 2020-09-30 | -$370.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$857.00K derived: sum of 2 quarters · filed 2021-11-04 | -$1.56M 10-Q · filed 2021-11-04 | -$1.99M derived: sum of 4 quarters · filed 2022-02-23 | |||||
| 2020-06-30 | -$487.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$1.19M 10-Q · filed 2021-08-04 | -$1.62M derived: sum of 3 quarters · filed 2022-02-23 | -$2.33M derived: sum of 4 quarters · filed 2022-02-23 | |||||
| 2020-03-31 | -$701.00K 10-Q · filed 2021-05-05 | -$1.14M derived: sum of 2 quarters · filed 2022-02-23 | -$1.84M derived: sum of 3 quarters · filed 2022-02-23 | -$2.42M derived: sum of 4 quarters · filed 2022-02-23 | |||||
| 2019-12-31 | -$434.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$1.14M derived: sum of 2 quarters · filed 2022-02-23 | -$1.71M derived: sum of 3 quarters · filed 2022-02-23 | -$2.42M 10-K · filed 2022-02-23 | |||||
| 2019-09-30 | -$709.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$1.28M derived: sum of 2 quarters · filed 2020-11-04 | -$1.99M 10-Q · filed 2020-11-04 | -$1.99M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2019-06-30 | -$571.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$1.28M 10-Q · filed 2020-08-05 | -$1.28M derived: sum of 3 quarters · filed 2021-02-25 | -$1.28M derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2019-03-31 | -$711.00K 10-Q · filed 2020-05-06 | -$711.00K derived: sum of 2 quarters · filed 2021-02-25 | -$711.00K derived: sum of 3 quarters · filed 2021-02-25 | -$711.00K derived: sum of 4 quarters · filed 2021-02-25 | |||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 | |||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | ||||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | ||||||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |